Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

US FDA approves revised SPA for Argos Therapeutics' phase III study of AGS ... - pharmabiz.com PDF Print
pharmabiz.com
Biopharmaceutical company Argos Therapeutics Inc. has received the US Food & Drug Administration (FDA) approval of revised Special Protocol Assessment (SPA) for its phase III clinical study of AGS-003 for the treatment of metastatic renal cell

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.